According to Straits Research, the global mRNA vaccines and therapeutics market size was worth USD 36.54 billion in 2022 and is estimated to reach an expected value of USD 58.92 billion by 2031, growing at a CAGR of 13.3% during the forecast period (2023 – 2031).
Market Definition
The mRNA Vaccines and Therapeutics Market refers to the biotechnology sector focused on developing and commercializing messenger RNA (mRNA)-based vaccines and therapeutics. mRNA technology enables cells to produce specific proteins that help the immune system recognize and combat diseases. This technology has revolutionized vaccine development by offering faster production timelines and high efficacy rates.
Get Free Exclusive PDF Request Sample Copy of This Research ? https://straitsresearch.com/report/mrna-vaccines-and-therapeutics-market/request-sample
Leading Companies in the mRNA Vaccines and Therapeutics Market
The competitive landscape of the mRNA Vaccines and Therapeutics Market is characterized by the presence of key players driving innovation and expansion. Prominent companies include:
Arcturus Therapeutics Holdings Inc
BioNTech SE
Daiichi Sankyo Company
CureVac N.V
Limited
ethris GmbH
GlaxoSmithKline plc
Gennova Biopharmaceuticals Ltd
Genova Biopharmaceuticals Ltd
Moderna Inc
Panthera Therapeutics GmbH
Providence Therapeutics
Silence Therapeutics
Latest Trends
Recent trends in the market include the expansion of mRNA vaccine applications beyond COVID-19, with research focusing on oncology, infectious diseases, and rare genetic disorders. Additionally, advancements in lipid nanoparticle (LNP) delivery systems and self-amplifying mRNA platforms are enhancing the stability and efficiency of mRNA therapeutics. Collaborations between biotech firms and pharmaceutical giants are also accelerating research and development (R&D) efforts, leading to rapid innovation in the field.
Key Opportunities Driving Market Growth
Increasing demand for personalized medicine and precision therapies.
Expansion of mRNA vaccine applications beyond COVID-19.
Strong government and private sector investments in mRNA technology.
Technological advancements in mRNA stability and delivery systems.
Growth in partnerships between biotech companies and pharmaceutical firms.
Market Segment Breakdown
By Application:
COVID-19 mRNA Vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA Vaccines
Oncology
Infectious Diseases
Other Diseases
By mRNA Type:
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Emerging Prospects in the mRNA Vaccines and Therapeutics Market
With the success of COVID-19 mRNA vaccines, companies are shifting their focus toward broader applications, including cancer immunotherapy, rare genetic disease treatments, and flu vaccines. The development of combination vaccines utilizing mRNA technology is also gaining traction, offering potential solutions for multi-disease prevention.
Buy Now@ https://straitsresearch.com/buy-now/mrna-vaccines-and-therapeutics-market
Industry Movements and Strategic Developments
The industry is witnessing substantial investment in R&D, with a strong push for next-generation mRNA vaccines. Companies are forming strategic alliances to advance clinical trials and improve manufacturing capabilities. Governments worldwide are supporting mRNA research initiatives through funding programs and regulatory incentives.
Geographic Analysis of the mRNA Vaccines and Therapeutics Market
North America: Dominates the market due to high investment in biotechnology, strong healthcare infrastructure, and established key players like Moderna and BioNTech.
Europe: Witnessing steady growth with increasing government funding and research initiatives.
Asia-Pacific: Expected to be the fastest-growing region, driven by increasing investments in biotech startups and expanding healthcare access.
Latin America & Middle East & Africa: Emerging markets with potential growth opportunities due to improving healthcare infrastructure and rising vaccine demand.
Market Data Insights and Future Outlook
The mRNA Vaccines and Therapeutics Market is poised for exponential growth as advancements in mRNA technology continue to revolutionize the medical field. The expansion of mRNA applications beyond COVID-19, coupled with innovations in drug delivery and stabilization techniques, will be critical in shaping the future of the market. As biotechnology firms refine their approaches and governments push for greater funding, the industry is set to witness transformative advancements in personalized medicine and vaccine development.
About Straits Research
Straits Research is a top provider of business intelligence, specializing in research, analytics, and advisory services, with a focus on delivering in-depth insights through comprehensive reports.
Contact Us:
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
